Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
iKang Healthcare Group Inc

KANG

iKang Healthcare Group Inc

iKang Healthcare Group Inc historical holders

total: 2

Joho Capital iKang Healthcare Group Inc transactions over time

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2015 Q2
Held for:
2 quarters
Latest activity:
2015 Q4
Robert Karr has been an institutional investor in iKang Healthcare Group Inc (KANG) since 2015 Q2. According to 2026 Q1 report, Robert Karr doesn't hold any shares. The fund/company first acquired KANG in 2015 Q2, initially purchasing about 2.82M shares. Since the initial investment, Joho Capital has made 2 more transactions in this position.

When did Robert Karr exit their KANG position?

Robert Karr no longer holds iKang Healthcare Group Inc (KANG). They sold off their entire position in 2015 Q4, closing out an investment that began in 2015 Q2.

When did Robert Karr first invest in KANG?

Robert Karr first invested in iKang Healthcare Group Inc (KANG) in 2015 Q2 at the reported quarter-end price of $19.34 per share, acquiring 2,822,655 shares in their initial purchase.

What is Robert Karr's average cost basis for KANG?

Based on historical transaction data, Robert Karr's estimated cost basis for iKang Healthcare Group Inc (KANG) is approximately $19.34 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$19.34
Weighted AVG sell price:
$14.80

KANG transactions history by Joho Capital

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2015 Q4
0.00%
$14.80
-100% (-1,290,268)
2015 Q3
5.47%
$14.80
-54.29% (-1,532,387)
2015 Q2
12.72%
$19.34
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.